No Independent Influence of Statins on the Chronic Obstructive Pulmonary Disease Exacerbation Rate: A Cohort Observation Study Over 10 Years
Authors:
Open Access
- 1 June 2021
- journal article
- research article
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 14, 2883-2892
Abstract
Purpose: Some previously published primarily retrospective studies have shown that statins could reduce the rate and severity of exacerbations, the length of hospital stays, and mortality in patients with chronic obstructive pulmonary disease (COPD), but retrospective data needs to be reviewed regarding this connection since statins are cholesterol-lowering drugs. Therefore, the aim of this study was to investigate the independent influence of statins on the exacerbation rate in COPD patients. Methods: An observational retrospective study was conducted to assess the independent influence of statins on the COPD exacerbation rate at the Department of Internal Medicine, Pulmonary Division, Internal Intensive Care Medicine, Infectiology, and Sleep Medicine, Märkische Clinics Health Holding Ltd, Clinic Lüdenscheid, Witten/Herdecke University from January 1, 2010 to December 31, 2020. This study enrolled patients with COPD in 2010 and documented their exacerbation rate over a further 10 years. The number of exacerbations in COPD patients was compared between statin users and non-users. Results: Of the total of 295 [176 male (59.7%)] COPD patients, 105 (35.6%, CI 30.3– 41.2%) patients with COPD were treated with statins, and 190 (64.4%, CI 58.8– 69.7%) were treated without statins. The mean exacerbation rate in the COPD patients who received statin did not differ from that in the COPD patients who did not receive statin (p = 0.175). Also, the mortality rates did not differ between the statin-treated and non-statin-treated COPD patients (p = 0.271). Conclusion: Statins have no effect on the exacerbation rate or mortality in COPD patients.Keywords
This publication has 35 references indexed in Scilit:
- Cholesterinhomöostase und kardiovaskuläres RisikoDMW - Deutsche Medizinische Wochenschrift, 2010
- Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) MeasureValue in Health, 2010
- Associations between statins and COPD: a systematic reviewBMC Pulmonary Medicine, 2009
- Defining Comorbidity: Implications for Understanding Health and Health ServicesThe Annals of Family Medicine, 2009
- Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort studyInternational Journal Of Clinical Practice, 2008
- Usefulness of C-Reactive Protein and Interleukin-6 as Predictors of Outcomes in Patients With Chronic Obstructive Pulmonary Disease Receiving PravastatinThe American Journal of Cardiology, 2008
- Statin Use Reduces Decline in Lung FunctionAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Statin use is associated with reduced mortality in COPDEuropean Respiratory Journal, 2006
- Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary DiseaseJACC, 2006
- HMG-CoA Reductase Inhibitors Inhibit Endothelial Exocytosis and Decrease Myocardial Infarct SizeCirculation Research, 2005